BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ablynx 

Technologiepark 4

Ghent  Zwijnaarde  9052  Belgium
Phone: 32-0-9-261-06-32 Fax: 32-0-9-261-06-28


SEARCH JOBS








 Company News
Ablynx Starts Pre-Clinical Development of ALX-0962, an Anti-IgE Nanobody, to Treat Severe Allergic Asthma 5/7/2013 10:21:25 AM    More...
Ablynx Announces Warrant Exercise 4/22/2013 12:18:44 PM    More...
Ablynx: Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (the "Transparency Law") 4/17/2013 10:52:22 AM    More...
Notice of Ablynx's Annual and Extraordinary General Meeting of Shareholders 3/26/2013 10:07:27 AM    More...
Ablynx: Publication in Accordance With Articles 14 and 15 of the Belgian Law of 2 May 2007 on the Publication of Major Shareholdings 3/11/2013 9:34:01 AM    More...
Ablynx Successfully Raises $41 Million 2/28/2013 8:59:53 AM    More...
Ablynx Announces 2012 Full Year Results 2/27/2013 10:36:30 AM    More...
Ablynx and Spirogen Ltd. Enter Into a Research Collaboration to Evaluate the Potential of Novel Toxin-Nanobody Drug Conjugates in Cancer 2/25/2013 9:57:26 AM    More...
Synthetic Llama Antibodies Soothe Arthritis Pain, Ablynx Reveals 2/22/2013 7:26:49 AM    More...
Ablynx Promoted to the Belgian Mid-Cap Index 2/21/2013 8:38:31 AM    More...
12345678910...